• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哌甲酯使用中的安全问题。美国视角。

Safety issues in the use of methylphenidate. An American perspective.

作者信息

Rappley M D

机构信息

Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, USA.

出版信息

Drug Saf. 1997 Sep;17(3):143-8. doi: 10.2165/00002018-199717030-00001.

DOI:10.2165/00002018-199717030-00001
PMID:9306050
Abstract

Methylphenidate is the most widely use psychotropic medication in children in the US. It is both well tolerated and efficacious in the treatment of attention deficit hyperactivity disorder, and is associated with few serious adverse effects. However, the abuse of methylphenidate for the purpose of experiencing a 'high' is hazardous. The use of methylphenidate in combination with other medications increases the risk of adverse effects and drug interactions. Good communication between the physician, patient and family, together with monitoring, increases the likelihood that methylphenidate therapy will be effective and have no adverse consequences.

摘要

哌甲酯是美国儿童中使用最广泛的精神药物。它在治疗注意力缺陷多动障碍方面耐受性良好且疗效显著,严重不良反应较少。然而,滥用哌甲酯以寻求“快感”是有害的。将哌甲酯与其他药物联合使用会增加不良反应和药物相互作用的风险。医生、患者和家属之间的良好沟通以及监测,会增加哌甲酯治疗有效的可能性且不会产生不良后果。

相似文献

1
Safety issues in the use of methylphenidate. An American perspective.哌甲酯使用中的安全问题。美国视角。
Drug Saf. 1997 Sep;17(3):143-8. doi: 10.2165/00002018-199717030-00001.
2
Azstarys (serdexmethylphenidate/dexmethylphenidate) for ADHD.用于治疗注意力缺陷多动障碍(ADHD)的Azstarys(右苯丙胺/右哌甲酯)
Med Lett Drugs Ther. 2021 Oct 4;63(1634):157-159.
3
Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.注意力缺陷/多动障碍学龄前儿童使用兴奋剂药物的短期副作用增加:一项双盲安慰剂对照研究。
J Child Adolesc Psychopharmacol. 1998;8(1):13-25. doi: 10.1089/cap.1998.8.13.
4
Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.随机对照双盲试验研究最佳剂量哌醋甲酯治疗伴有严重注意缺陷多动障碍和智力障碍的儿童和青少年。
J Child Psychol Psychiatry. 2013 May;54(5):527-35. doi: 10.1111/j.1469-7610.2012.02569.x. Epub 2012 Jun 7.
5
Combining methylphenidate and clonidine: a clinically sound medication option.哌甲酯与可乐定联用:一种临床合理的药物选择。
J Am Acad Child Adolesc Psychiatry. 1999 May;38(5):614-9; discussion 619-22. doi: 10.1097/00004583-199905000-00025.
6
Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.每日一次的渗透泵型哌甲酯对患有注意力缺陷/多动障碍的青少年来说是安全且耐受性良好的。
J Child Adolesc Psychopharmacol. 2006 Jun;16(3):351-6. doi: 10.1089/cap.2006.16.351.
7
Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.哌甲酯:对其神经药理学、神经心理学及临床不良反应的综述
Hum Psychopharmacol. 2004 Apr;19(3):151-80. doi: 10.1002/hup.579.
8
Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.联合使用兴奋剂和胍法辛治疗注意力缺陷多动障碍:一项对照比较研究。
J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):657-666.e1. doi: 10.1016/j.jaac.2016.05.015. Epub 2016 Jun 3.
9
Adverse response to methylphenidate in combination with valproic acid.
J Child Adolesc Psychopharmacol. 2000 Spring;10(1):39-43. doi: 10.1089/cap.2000.10.39.
10
[Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].[兴奋剂和非兴奋剂对成人注意力缺陷多动障碍(ADHD)的疗效与安全性]
Harefuah. 2011 Oct;150(10):788-90, 814.

引用本文的文献

1
Fighting fair: community perspectives on the fairness of performance enhancement in esports.公平竞争:社区对电子竞技中提高成绩的公平性的看法。
Front Sports Act Living. 2024 Mar 12;6:1330755. doi: 10.3389/fspor.2024.1330755. eCollection 2024.
2
From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate.从临床应用到认知增强:哌甲酯的实例
Curr Neuropharmacol. 2016;14(1):17-27. doi: 10.2174/1570159x13666150407225902.
3
Misuse of stimulant medication among college students: a comprehensive review and meta-analysis.

本文引用的文献

1
Using psychostimulants to treat behavioral disorders of children and adolescents.
J Child Adolesc Psychopharmacol. 1990 Spring;1(1):7-20. doi: 10.1089/cap.1990.1.7.
2
Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose.注意缺陷多动障碍合并抽动秽语综合征的受控兴奋剂治疗:兴奋剂及剂量的影响
J Am Acad Child Adolesc Psychiatry. 1997 May;36(5):589-96. doi: 10.1097/00004583-199705000-00008.
3
Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms.慢性治疗期间因丙咪嗪和地昔帕明代谢物蓄积导致两名受试者死亡:文献综述及可能机制
大学生滥用兴奋剂药物:综合回顾和荟萃分析。
Clin Child Fam Psychol Rev. 2015 Mar;18(1):50-76. doi: 10.1007/s10567-014-0177-z.
4
Methylphenidate and suicidal ideation: Report of two cases.哌醋甲酯与自杀意念:两例报告。
Indian J Psychiatry. 2014 Jan;56(1):79-81. doi: 10.4103/0019-5545.124721.
5
Comorbidities in ADHD children treated with methylphenidate: a database study.注意缺陷多动障碍儿童在使用哌醋甲酯治疗中的共病情况:数据库研究。
BMC Psychiatry. 2013 Jan 7;13:11. doi: 10.1186/1471-244X-13-11.
6
Assessing methylphenidate preference in ADHD patients using a choice procedure.使用选择程序评估多动症患者对哌甲酯的偏好。
Psychopharmacology (Berl). 2004 Oct;175(4):391-8. doi: 10.1007/s00213-004-1838-2.
7
Methylphenidate Abuse and Psychiatric Side Effects.哌甲酯滥用与精神科副作用
Prim Care Companion J Clin Psychiatry. 2000 Oct;2(5):159-164. doi: 10.4088/pcc.v02n0502.
8
Extended-release methylphenidate (Ritalin LA).缓释哌醋甲酯(利他林长效型)。
Drugs. 2002;62(15):2251-9; discussion 2260-1. doi: 10.2165/00003495-200262150-00012.
9
Dexmethylphenidate.右旋哌甲酯
Drugs. 2002;62(13):1899-904; discussion 1905-8. doi: 10.2165/00003495-200262130-00009.
J Forensic Sci. 1997 Mar;42(2):335-9.
4
Case study: two additional sudden deaths with tricyclic antidepressants.
J Am Acad Child Adolesc Psychiatry. 1997 Mar;36(3):390-4. doi: 10.1097/00004583-199703000-00018.
5
Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?癫痫与注意力缺陷多动障碍:哌甲酯安全有效吗?
J Pediatr. 1997 Jan;130(1):40-4. doi: 10.1016/s0022-3476(97)70308-1.
6
Increased methylphenidate usage for attention deficit disorder in the 1990s.20世纪90年代用于治疗注意力缺陷障碍的哌醋甲酯使用量增加。
Pediatrics. 1996 Dec;98(6 Pt 1):1084-8.
7
Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle.注意力缺陷多动障碍全生命周期的药物治疗
J Am Acad Child Adolesc Psychiatry. 1996 Apr;35(4):409-32. doi: 10.1097/00004583-199604000-00008.
8
Use of stimulants in the medically ill.兴奋剂在患有内科疾病者中的应用。
Psychiatr Clin North Am. 1996 Sep;19(3):515-47. doi: 10.1016/s0193-953x(05)70304-x.
9
Attention deficit disorder: a review of the past 10 years.注意力缺陷障碍:过去十年综述
J Am Acad Child Adolesc Psychiatry. 1996 Aug;35(8):978-87. doi: 10.1097/00004583-199608000-00008.
10
Experimental studies on the long-term effects of methylphenidate hydrochloride.盐酸哌甲酯长期影响的实验研究
Toxicology. 1995 Nov 30;103(2):77-84. doi: 10.1016/0300-483x(95)03109-s.